Naturmega to Introduce SUPRIAX2™ and Showcase Next-Generation Lipid Innovation at SupplySide Global 2026
Naturmega, an advanced lipid science company focused on omega-3 and next-generation lipid technologies, is preparing to introduce SUPRIAX2™ to the North American market at SupplySide Global 2026 in Las Vegas. The new ingredient represents the first market-ready solution within the company’s BeyondKrill™ platform, an initiative aimed at redefining how omega-3 ingredients are developed, formulated and delivered.
The introduction reflects Naturmega’s broader vision for the future of omega-3 innovation. While much of the industry’s development over the past several decades has centered on the source of omega-3 fatty acids and the concentration that can be achieved, Naturmega believes the next stage of innovation will focus increasingly on lipid structure and intentional design.
With SUPRIAX2™, the company is seeking to move the conversation beyond simply asking where omega-3 comes from or how much EPA and DHA an ingredient contains. Instead, Naturmega is emphasizing how these fatty acids can be structurally designed and delivered to support formulation flexibility, potency and the overall consumer experience.
The North American launch at SupplySide Global will give brands, formulators and industry professionals an opportunity to learn more about the ingredient and Naturmega’s expanding portfolio of lipid technologies.
A New Approach to Omega-3 Design
Omega-3 ingredients have traditionally been differentiated according to their marine or algal sources, EPA and DHA concentration, purity, stability, sensory characteristics and formulation performance. As the category continues to mature, ingredient developers are exploring additional ways to improve how omega-3 fatty acids are incorporated into finished products.
Naturmega’s BeyondKrill™ concept is based on the idea that lipid architecture itself can become an important area of innovation.
SUPRIAX2™ is powered by Ruby-O®, the company’s proprietary lipid-design technology. Rather than simply combining omega-3 fatty acids with phospholipids, Ruby-O® uses an enzymatic process to bond omega-3 fatty acids to phospholipids.
According to Naturmega, this structured approach is intended to create a differentiated lipid system that can provide brands with greater flexibility when developing nutritional products.
Jorge Atencio, Chief Operating Officer at Naturmega, said the omega-3 category has historically focused on the origin and concentration of omega-3. He explained that the company believes the next important question concerns how intelligently the lipid can be designed and delivered.
Atencio described BeyondKrill™ as Naturmega’s next frontier in omega-3 innovation and SUPRIAX2™ as the first commercially ready product to demonstrate this lipid-design strategy.
SUPRIAX2™ Combines Potency and Formulation Flexibility
SUPRIAX2™ provides 450 milligrams of EPA and DHA per suggested daily serving. Naturmega positions this level as approximately twice the omega-3 strength of conventional krill oil, while also delivering a greater amount of omega-3 bonded to phospholipids.
The ingredient is also shellfish-free, an attribute that may broaden its potential use among brands and consumers seeking alternatives to traditional krill-derived omega-3 products.
Another key feature is its neutral sensory profile. Sensory characteristics can be an important consideration when developing omega-3 supplements and functional foods because unpleasant taste or odor can affect consumer acceptance. By providing a neutral sensory experience, SUPRIAX2™ is designed to give formulators additional options for incorporating omega-3 into different product formats.
The combination of omega-3 potency, phospholipid bonding and sensory characteristics is intended to make the ingredient suitable for a range of applications.
Rather than restricting omega-3 delivery to conventional softgel formats, Naturmega is exploring opportunities to incorporate advanced lipid ingredients into products such as gummies, powders, beverages, purées, gels, chewables and softgels.
This application flexibility is increasingly important as consumers seek nutritional products that fit different preferences and lifestyles.
Ruby-O® Technology Forms the Foundation
At the heart of SUPRIAX2™ is Naturmega’s Ruby-O® platform. The proprietary technology uses enzymatic processing to create omega-3 fatty acids bonded to phospholipids, producing what the company describes as a structured lipid system.
The distinction between bonded and blended ingredients is central to Naturmega’s approach. Instead of simply mixing omega-3 with phospholipids, Ruby-O® is designed to create a more intentional relationship between the two lipid components.
Naturmega believes this approach can give product developers greater control when designing nutritional products around specific formulation, positioning and performance objectives.
The company is also supporting the Ruby-O® platform with clinical research examining how its bonded phospholipid structure may influence omega-3 delivery and incorporation.
Early research findings have indicated potential advantages compared with conventional fish oil, while additional studies are underway. These ongoing investigations are intended to provide a deeper understanding of the relationship between lipid structure, phospholipid delivery and omega-3 utilization.
As research progresses, Naturmega expects the findings to contribute to the scientific foundation supporting its next-generation lipid technologies.
BeyondKrill™ Looks Beyond Traditional Omega-3 Categories
The BeyondKrill™ platform represents Naturmega’s effort to create omega-3 solutions that extend beyond conventional source-based distinctions.
Krill oil has historically occupied a distinctive position in the omega-3 market because of its natural association with phospholipids. Naturmega’s approach seeks to take the concept of omega-3 bonded to phospholipids further through deliberate lipid engineering.
SUPRIAX2™ therefore represents a new category proposition for the company. Instead of relying exclusively on the natural source of the ingredient, Naturmega is using lipid design as a tool for developing a market-ready omega-3 solution.
This approach could allow brands to explore new product concepts without being limited by traditional ingredient formats.
The company will use SupplySide Global 2026 to demonstrate how its technology platforms can support both immediate formulation requirements and longer-term product development strategies.
Two Complementary Solution Platforms
At SupplySide Global, Naturmega plans to showcase two broad solution platforms designed to address different needs within the nutritional ingredient market.
The company’s Essential Solutions portfolio is focused on practical requirements faced by brands seeking reliable and scalable omega-3 ingredients. These solutions include technologies and ingredients aimed at improving sensory performance, providing marine and algal sourcing options, increasing supply resilience, delivering higher omega-3 concentrations and supporting greater flexibility in finished product formats.
This part of the portfolio is intended to address established market requirements and help brands move products efficiently toward commercialization.
The second platform, Next-Generation Solutions, focuses on emerging science, intentional lipid design and proprietary technologies intended to support differentiated nutritional products.
SUPRIAX2™ sits within this second category as the first market-ready expression of Naturmega’s BeyondKrill™ concept.
Together, the two platforms are designed to demonstrate that brands may require different types of ingredient solutions depending on their product development objectives.
Expanding the Naturmega Portfolio
Beyond SUPRIAX2™, visitors to Naturmega’s SupplySide Global booth will be able to explore several other technologies and ingredient platforms.
The company will showcase Ruby-O® bonded phospholipid technology alongside SENSES™, which is designed to provide a clearer and more neutral omega-3 sensory experience.
Naturmega will also present Algalis®, its algal DHA solution, as well as Dualis™, a dual-origin marine and algal omega-3 offering. The company’s EssentiOmega® portfolio will also be featured as part of its broader range of scalable omega-3 solutions.
The portfolio demonstrates Naturmega’s focus on offering multiple approaches to omega-3 formulation rather than relying on a single ingredient or source.
Different brands may have different requirements based on their target consumers, product format, nutritional claims, supply-chain considerations and desired market positioning. By providing multiple platforms, Naturmega aims to support both established omega-3 products and emerging nutritional concepts.
Demonstrating New Product Formats
Another major focus of Naturmega’s presence at SupplySide Global will be application development.
The company plans to showcase concepts demonstrating how advanced lipid technologies can be incorporated into a broad range of consumer-friendly formats. These include gummies, powders, beverages, purées, gels, chewables and traditional softgels.
This focus on applications reflects a wider shift in the nutritional supplement market toward more convenient and enjoyable delivery formats.
While softgels remain an important format for omega-3 supplementation, consumers increasingly have access to products designed to provide nutritional ingredients in alternative forms. Formulators therefore need ingredients that can perform effectively across different manufacturing processes and product types.
Naturmega’s application concepts are intended to illustrate how its lipid technologies can be adapted to these evolving requirements.
Joel Minski, Chief Strategy Officer at Naturmega, said brands approach the company with a wide range of challenges. Some customers may be looking for improved sensory performance, alternative sourcing options or greater supply flexibility, while others may be seeking highly differentiated technologies for future product generations.
According to Minski, Naturmega’s portfolio is designed to support both immediate commercialization needs and longer-term innovation objectives.
SupplySide Global 2026 Provides Launch Platform
Naturmega will introduce SUPRIAX2™ to the North American market during SupplySide Global 2026 in Las Vegas. The event is expected to bring together ingredient suppliers, manufacturers, formulators, researchers, brand owners and other stakeholders from the health and nutrition industries.
Naturmega will exhibit at booth 6643, where attendees will be able to meet members of the company’s commercial, scientific and innovation teams.
Visitors will have the opportunity to learn more about SUPRIAX2™, explore the Ruby-O® platform and review other omega-3 technologies in the Naturmega portfolio. The company will also present application concepts designed to demonstrate how its ingredients can be incorporated into different consumer product formats.
The event will provide an opportunity for companies developing nutritional supplements and functional products to discuss potential applications and commercialization opportunities directly with Naturmega’s technical and commercial teams.
Building the Next Generation of Omega-3 Innovation
The introduction of SUPRIAX2™ represents a strategic milestone in Naturmega’s efforts to broaden the definition of omega-3 innovation. The company is moving beyond traditional considerations such as source and concentration to focus on lipid architecture, structural design and delivery.
With its Ruby-O® technology and BeyondKrill™ platform, Naturmega is pursuing an approach in which omega-3 ingredients are intentionally engineered to address specific formulation and product-development objectives.
The company’s investment in research, technology development and application concepts also reflects its broader ambition to help brands create differentiated nutritional products.
As the omega-3 market continues to evolve, factors such as sensory experience, format flexibility, supply resilience and ingredient functionality are likely to remain important considerations for product developers. At the same time, advances in lipid science may open new opportunities for designing ingredients around specific nutritional and formulation goals.
SUPRIAX2™ is positioned as Naturmega’s first market-ready solution within this emerging area of lipid design. Its launch at SupplySide Global 2026 will give the company an opportunity to introduce the technology to North American customers while demonstrating how its broader portfolio can address both current and future omega-3 requirements.
Through its Essential Solutions and Next-Generation Solutions platforms, Naturmega is ultimately seeking to provide brands with a combination of established, scalable ingredients and emerging technologies. The company’s expanding portfolio, together with ongoing research into bonded phospholipid structures, underscores its commitment to advancing omega-3 science and creating new possibilities for nutritional product development.
About Naturmega
Naturmega is an advanced lipid science company redefining how omega-3 and specialized lipids are designed, manufactured and brought to market. From high-quality marine and algal omega-3 ingredients to proprietary bonded phospholipid technologies, Naturmega combines scientific expertise, advanced manufacturing and application development to help brands create differentiated and commercially viable products.
Through its Essential Solutions and Next-Generation Solutions platforms, Naturmega supports brands and CDMOs with both market-ready ingredients and emerging lipid technologies designed to shape what comes next in nutritional health.